［1］Onitilo AA，Engel JM，Glurich I，et al.Diabetes and cancer I：risk，survival，and implications for screening［J］.Cancer Causes Control，2012，23(6)：967-981.
［2］Sánchez Peralta AM，Oliveras-López MJ，Pérez González R，et al.Prevalence of diabetes in a cancer population in a Malaga hospital［J］.Nutr Hosp，2012，27(2)：456-462.
［3］Zanders MM，Vissers PA，Haak HR，et al.Colorectal cancer，diabetes and survival：epidemiological insights［J］.Diabetes Metab，2014，40(2)：120-127.
［4］Raff EJ，Kakati D，Bloomer JR，et al.Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases［J］.J Clin Transl Hepatol，2015，3(1)：9-16.
［5］Wang P，Kang D，Cao W，et al.Diabetes mellitus and risk of hepatocellular carcinoma：a systematic review and Meta-analysis［J］.Diabetes Metab Res Rev.2012，28(2)：109-122.
［6］Arase Y，Kobayashi M，Suzuki F，et al.Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C［J］.Hepatology，2013，57(3)：964-973.
［7］Li CI，Chen HJ，Lai HC，et al.Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes-National cohort of Taiwan Diabetes Study［J］.Int J Cancer，2015，136(11)：2668-2679.
［8］Barone BB，Yeh HC，Snyder CF，et al.Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus：a systematic review and meta-analysis［J］.JAMA，2008，300(23)：2754-2764.
［9］Hassan MM，Curley SD，Kaseb A，et al.Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma［J］.Cancer，2010，116(8)：1938-1946.
［10］Schlesinger S，Aleksandrova K，Pischon T，et al.Diabetes mellitus，insulin treatment，diabetes duration，and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort［J］.Ann Oncol，2013，24(9)：2449-2455.
［11］Zhang PH，Chen ZW，Lv D，et al.Increased risk of cancer in patients with type 2 diabetes mellitus：a retrospective cohort study in China［J］.BMC Public Health，2012，12：567.
［12］Gallagher EJ，LeRoith D.The proliferating role of insulin and insulin-like growth factors in cancer［J］.Trends Endocrinol Metab，2010，21(10)：610-618.
［13］Komura T，Sakai Y，Honda M，et al.CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes［J］.Diabetes，2010，59(3)：634-643.
［14］Lecube A，Pachón G，Petriz J，et al.Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement［J］.PLoS One，2011，6(8)：e23366.
［15］Sgambato A，Cittadini A.Inflammation and cancer：a multifaceted link［J］.Eur Rev Med Pharmacol Sci，2010，14(4)：263-268.
［16］Godsland IF.Insulin resistance and hyperinsulinaemia in the development and progression of cancer［J］.2009，118(5)：315-332.
［17］Plate KH，Scholz A，Dumont DJ.Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited［J］.Acta Neuropathol，2012，124(6)：763-775.
［18］Kusumanto YH，Meijer C，Dam W，et al.Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical ischemia［J］.Drug Target Insights，2007，2：105-109.
［19］Rolo AP，Palmeira CM.Diabetes and mitochondrial function：role of hyperglycemia and oxidative stress［J］.Toxicol Appl Pharmacol，2006，212(2)：167-178.
［20］Li ZY，Yang Y，Ming M，et al.Mitochondrial ROS generation for regulation of autophagic pathways in cancer［J］.Biochem Biophys Res Commun，2011，414(1)：5-8.
［21］Rojas A，González I，Morales E，et al.Diabetes and cancer：Looking at the multiligand/RAGE axis［J］.World J Diabetes，2011，2(7)：108-113.
［22］Bosetti C，Franchi M，Nicotra F，et al.Insulin and other antidiabetic drugs and hepatocellular carcinoma risk：a nested case-control study based on Italian healthcare utilization databases［J］.Pharmacoepidemiol Drug Saf，2015，24(7)：771-778.
［23］Eikawa S，Nishida M，Mizukami S，et al.Immune-mediated antitumor effect by type 2 diabetes drug，metformin［J］.Proc Natl Acad Sci U S A，2015，112(6)：1809-1814.
［24］Zheng L，Yang W，Wu F，et al.Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma［J］.Clin Cancer Res，2013，19(19)：5372-5380.
［25］Bhalla K，Hwang BJ，Dewi RE，et al.Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis［J］.Cancer Prev Res (Phila)，2012，5(4)：544-552.
［26］Miele L，Bosetti C，Turati F，et al.Diabetes and insulin therapy，but not metformin，are related to hepatocellular cancer risk［J］.Gastroenterol Res Pract，2015，2015：570356.
［27］Singh S，Singh PP，Singh AG，et al.Anti-diabetic medications and the risk of hepatocellular cancer：a systematic review and meta-analysis［J］.Am J Gastroenterol，2013，108(6)：881-891.
［28］Seo YS，Kim YJ，Kim MS，et al.Association of metformin use with cancer-specific mortality in hepatocellular carcinoma after curative resection：a nationwide population-based study［J］.Medicine (Baltimore)，2016，95(17)：e3527.
［29］Bhat M，Chaiteerakij R，Harmsen WS，et al.Metformin does not improve survival in patients with hepatocellular carcinoma［J］.World J Gastroenterol，2014，20(42)：15750-15755.
［30］Yang X，Wang Y，Luk AO，et al.Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes［J］.Endocr Relat Cancer，2013，20(2)：161-171.
［31］Monami M，Lamanna C，Balzi D，et al.Sulphonylureas and cancer：a case-control study［J］.Acta Diabetol，2009，46(4)：279-284.
［32］Currie CJ，Poole CD，Gale EA.The influence of glucose-lowering therapies on cancer risk in type 2 diabetes［J］.Diabetologia，2009，52(9)：1766-1777.
［33］Tsilidis KK，Capothanassi D，Allen NE，et al.Metformin does not affect cancer risk：a cohort study in the U.K.Clinical Practice Research Datalink analyzed like an intention-to-treat trial［J］.Diabetes Care，2014，37(9)：2522-2532.
［34］Li XQ，Sun GP.Relationship between chemotherapy and blood glucose of patients with malignancy［J］.Qingdao Med J，2014，46(3)：194-195.
［35］Luo K.Effects of chemotherapy on glycated hemoglobin and fasting plasma glucose in patients with malignant tumor［J］.Laboratory Medicine and Clinic，2014，12(8)：1025-1027.
［36］Liu L.Study on chemotherapy-induced glucose metabolic disorders and function of βCell of islet in patients with malignant neoplasm［D］.Hefei：Anhui Medical University，2012.
［37］Wang ZH，Cui H，Li XP，et al.Study on factors inducing diabetes mellitus after chemotherapy［J］.Chin J Clin Obstetric and Gynecol，2004，5(6)：416-419.
［38］Di Costanzo GG，Tortora R，Morisco F，et al.Impact of diabetes on outcomes of sorafenib therapy for hepatocellular carcinoma［J］.Target Oncol，2016.
［39］Masood MA，Zafar W，Yusuf MA.Is diabetes mellitus a poor prognostic factor for hepatocellular carcinoma［J］? J Gastrointest Cancer，2014，45(4)：448-451.
［40］Wang YY，Huang S，Zhong JH，et al.Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy［J］.PLoS One，2014，9(12)：e113858.
［41］Raffetti E，Portolani N，Molfino S，et al.Role of aetiology，diabetes，tobacco smoking and hypertension in hepatocellular carcinoma survival［J］.Dig Liver Dis，2015，47(11)：950-956.
［42］Wang YG，Wang P，Wang B，et al.Diabetes mellitus and poorer prognosis in hepatocellular carcinoma：a systematic review and Meta-analysis［J］.PLoS One，2014，9(5)：e95485.
［43］Zhang RL，Zhou SS，Xiao L，et al.Comparison of clinical characteristics of non-B non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma and prognosis in Uighur patients［J］.Chin J Oncol，2015，37(7)：540-544.
［44］Gao C，Zhao HC，Li JT，et al.Diabetes mellitus and hepatocellular carcinoma：comparison of Chinese patients with and without HBV-related cirrhosis［J］.World J Gastroenterol，2010，16(35)：4467-4475.
［45］Nkontchou G，Cosson E，Aout M，et al.Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients［J］.J Clin Endocrinol Metab，2011，96(8)：2601-2608.
［46］Kawamura Y，Ikeda K，Arase Y，et al.Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis［J］.J Gastroenterol Hepatol，2008，23(11)：1739-1746.
［47］Wang WM，Xu Y，Yang XR，et al.Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments：a Meta-analysis［J］.Hepatobiliary Pancreat Dis Int，2011，10(4)：346-355.
［48］Liu XH.Studies of diabetes mellitus and hepatocellular carcinoma［D］.Guangzhou：Southern Medical University，2014.